Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Newly identified genetic variants associated with idiosyncratic drug-induced liver injury.

Current opinion in gastroenterology - 1 May 2022

Stolz Andrew

Abstract excerpt

PURPOSE OF REVIEW: Datasets of well characterized drug or herbal and dietary supplement-associated liver injury has provided a rich resource to identify genetic variants associated with hepatic injury that further supports the role of immune activation in drug-induced liver injury (DILI). RECENT FINDINGS: Using DNA microarrays, whole genome sequencing, HLA-restricted DNA sequencing with appropriate ethnically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Aminopeptidases
Share to Chemical and Drug Induced Liver Injury

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA Antigens

Share to Protein Tyrosine Phosphatase, Non-Receptor Type 22

Share to Risk Factors

Source

Identifiers

PMID: 35645018
DOI: 10.1097/MOG.0000000000000822

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Newly identified genetic variants associated with idiosyncratic drug-induced liver injury.PMID 35645018Read ↗

Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.Semantic proximity Read ↗

Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.Semantic proximity Read ↗

Genetic risk factors in the development of idiosyncratic drug-induced liver injury.Semantic proximity Read ↗

Genetic and Genomic Approaches to the Study of Drug-Induced Liver Injury.Semantic proximity Read ↗

Genetic basis of drug-induced liver injury: present and future.Semantic proximity Read ↗

Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.Semantic proximity Read ↗

Genome-Wide Association Studies in Drug-Induced Liver Injury: Step Change in Understanding the Pathogenesis.Semantic proximity Read ↗

Genetics of drug-induced liver injury: Current knowledge and future prospects.Semantic proximity Read ↗

Drug-Induced Liver Injury: Insights from Genetic StudiesSemantic proximity Read ↗

Genetic and Epigenetic Basis of Drug-Induced Liver Injury.Semantic proximity Read ↗

Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Semantic proximity Read ↗

Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.